Oncogenic KRAS triggers metabolic reprogramming in pancreatic ductal adenocarcinoma

被引：7
|
作者：
Shen, Xuqing [1 ]
Niu, Ningning [1 ]
Xue, Jing [1 ]
机构：
[1] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Stem Cell Res Ctr, Ren Ji Hosp,Sch Med,Shanghai Canc Inst, Shanghai 200127, Peoples R China
来源：
JOURNAL OF TRANSLATIONAL INTERNAL MEDICINE | 2023年 / 11卷 / 04期
基金：
中国国家自然科学基金;
关键词：
pancreatic ductal adenocarcinoma; oncogenic KRAS activation; metabolic reprogramming; POSITRON-EMISSION-TOMOGRAPHY; FATTY-ACID-METABOLISM; GLUTAMINE-METABOLISM; TUMOR-GROWTH; GEMCITABINE RESISTANCE; CANCER GROWTH; CELL-GROWTH; K-RAS; GLUCOSE; INHIBITOR;
D O I：
10.2478/jtim-2022-0022
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Pancreatic ductal adenocarcinoma (PDAC) is a devastating disease with an extremely high lethality rate. Oncogenic KRAS activation has been proven to be a key driver of PDAC initiation and progression. There is increasing evidence that PDAC cells undergo extensive metabolic reprogramming to adapt to their extreme energy and biomass demands. Cell-intrinsic factors, such as KRAS mutations, are able to trigger metabolic rewriting. Here, we update recent advances in KRAS-driven metabolic reprogramming and the associated metabolic therapeutic potential in PDAC.
引用
收藏
页码：322 / 329
页数：8
相关论文
共 50 条
  • [1] Oncogenic Kras induces histone acetylation in pancreatic ductal adenocarcinoma
    Carrer, Alessandro
    Lee, Joyce V.
    Shah, Supriya
    Snyder, Nathaniel W.
    Jackson, Ellen
    Aiello, Nicole M.
    Garcia, Benjamin A.
    Chodosh, Lewis A.
    Stanger, Ben Z.
    Blair, Ian A.
    Wellen, Kathryn E.
    CANCER RESEARCH, 2015, 75
  • [2] PTGES Expression Is Associated with Metabolic and Immune Reprogramming in Pancreatic Ductal Adenocarcinoma
    Murthy, Divya
    Attri, Kuldeep S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (08)
  • [3] Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
    Alshaikh, Amani
    Grygoryev, Dmytro
    Keith, Dove
    Sheppard, Brett
    Sears, Rosalie C.
    Kim, Jungsun
    Soufi, Abdenour
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (204):
  • [4] Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal Adenocarcinoma
    Liang, Chen
    Qin, Yi
    Zhang, Bo
    Ji, Shunrong
    Shi, Si
    Xu, Wenyan
    Liu, Jiang
    Xiang, Jinfeng
    Liang, Dingkong
    Hu, Qiangsheng
    Ni, Quanxing
    Xu, Jin
    Yu, Xianjun
    MOLECULAR CANCER RESEARCH, 2017, 15 (02) : 201 - 212
  • [5] Differential Effects of Dietary Macronutrients on the Development of Oncogenic KRAS-Mediated Pancreatic Ductal Adenocarcinoma
    Zhu, Liang
    Ji, Juntao
    Ma, Jianjia
    Wang, Dan
    Liu, Muyun
    Du, James Xianxing
    Chen, Rong
    Hou, Wei
    Abbruzzese, James L.
    Logsdon, Craig D.
    Yang, Vincent W.
    Luo, Yongde
    Lu, Weiqin
    CANCERS, 2022, 14 (11)
  • [6] Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras
    Asahina, Kinji
    Balog, Steven
    Hwang, Edward
    Moon, Eugene
    Wan, Emily
    Skrypek, Kaitlin
    Chen, Yibu
    Fernandez, Jay
    Romo, Janet
    Yang, Qihong
    Lai, Keane
    French, Samuel W.
    Tsukamoto, Hidekazu
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2020, 318 (02): : G265 - G276
  • [7] An Oncogenic ALK Fusion and an RRAS Mutation in KRAS Mutation-Negative Pancreatic Ductal Adenocarcinoma
    Shimada, Yoko
    Kohno, Takashi
    Ueno, Hideki
    Ino, Yoshinori
    Hayashi, Hideyuki
    Nakaoku, Takashi
    Sakamoto, Yasunari
    Kondo, Shunsuke
    Morizane, Chigusa
    Shimada, Kazuaki
    Okusaka, Takuji
    Hiraoka, Nobuyoshi
    ONCOLOGIST, 2017, 22 (02): : 158 - 164
  • [8] Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma
    Hashimoto, Daisuke
    Arima, Kota
    Yokoyama, Naomi
    Chikamoto, Akira
    Taki, Katsunobu
    Inoue, Risa
    Kaida, Takayoshi
    Higashi, Takaaki
    Nitta, Hidetoshi
    Ohmuraya, Masaki
    Hirota, Masahiko
    Beppu, Toru
    Baba, Hideo
    PANCREAS, 2016, 45 (08) : 1111 - 1114
  • [9] Epigenetic Reprogramming in Patients With Pancreatic Ductal Adenocarcinoma
    Pin, C.
    Leslie, K.
    Ponich, T.
    Hussain, N.
    Johnson, C.
    PANCREAS, 2014, 43 (08) : 1401 - 1401
  • [10] p53 mutations cooperate with oncogenic Kras to promote adenocarcinoma from pancreatic ductal cells
    Bailey, J. M.
    Hendley, A. M.
    Lafaro, K. J.
    Pruski, M. A.
    Jones, N. C.
    Alsina, J.
    Younes, M.
    Maitra, A.
    McAllister, F.
    Iacobuzio-Donahue, C. A.
    Leach, S. D.
    ONCOGENE, 2016, 35 (32) : 4282 - 4288
12345